Trials / Unknown
UnknownNCT00662090
Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood
Prospective Non-randomized Multi-center Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 260 (estimated)
- Sponsor
- University Hospital Freiburg · Academic / Other
- Sex
- All
- Age
- 215 Months
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to improve the accuracy of diagnosis for children and adolescents with MDS by a standardized review of morphology and standardized cytogenetic and molecular analysis. The primary objectives of the study are: * To evaluate the frequency of the different subtypes of MDS in childhood and adolescence by a standardized diagnostic approach * To evaluate the frequency of cytogenetic and molecular abnormalities: Specifically using array-CGH to evaluate the frequency of subtle chromosomal imbalances, i.e. gains and losses of defined chromosomal regions, and amplifications. Specifically using mFISH to identify unknown chromosomal aberrations, particularly subtle translocations involving new candidate genes, and to better define chromosomal breakpoints. The secondary objectives of the study are: * To assess survival for children and adolescents with MDS and JMML * To evaluate relapse rate, morbidity and mortality in children with MDS and JMML treated by HSCT
Conditions
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2023-12-01
- Completion
- 2024-12-01
- First posted
- 2008-04-21
- Last updated
- 2023-05-24
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00662090. Inclusion in this directory is not an endorsement.